Case Study: Recurrence of Felty Syndrome Triggered by Immunotherapy in a Metastatic Melanoma Patient - Top-Institutions - MDSpire

Case Study: Recurrence of Felty Syndrome Triggered by Immunotherapy in a Metastatic Melanoma Patient

  • By

  • Laura S. Park

  • Caoimhe Byrne

  • Hayley Burridge

  • Wendy Zhu

  • Michelle Leech

  • Miles C. Andrews

  • April 20, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology
    • Rheumatology
    • Immunology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Oncology
    • Immunology

  • #3

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Oncology
    • Rheumatology
    • Immunology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Oncology
    • Immunology

Original Source(s)

Case Study: Recurrence of Felty Syndrome Triggered by Immunotherapy in a Metastatic Melanoma Patient

  • by Laura S. Park, Caoimhe Byrne, Hayley Burridge, Wendy Zhu, Michelle Leech, Miles C. Andrews

  • April 20, 2026

Related Content

Comparative efficacy of therapeutic modalities for metastatic uveal melanoma: a systemic review and network meta-analysis

2025 San Antonio Breast Cancer Symposium Recap

Harold Burstein, MD, PhD, summarizes important breakthroughs presented at the 2025 San Antonio Breast Cancer Symposium.

  • March 17, 2026

  • 1 min
Engineering CAR T Cells to Resist Tumor Immune Suppression

CRISPR editing removes PGE2 receptors from therapeutic T cells, improving persistence and tumor control in preclinical models

  • March 9, 2026

  • 2 min